HivNCT05642676
Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design
A study testing Clinics remodeling in people with Hiv, run by University of Minnesota at 1 site in United States.
Trial summary
The purpose of this study is to test the feasibility and acceptability of implementing clinic system changes and physical structures in Uganda to improve aesthetics, welcome, and privacy to reduce HIV stigma, improve retention-in-care, and improve the patient experience. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hiv
- What is being tested?
- Clinics remodeling
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 30 Jul 2024to 30 Jul 2027
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults 18 and older
- Enrolled in the HIV clinics where we are working
- Able to independently consent for interview, survey, or focus group.
Who cannot join
- Unable to provide consent
- Does not speak English or Luganda (local language around Kampala and Entebbe)
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Minnesota
Minneapolis, Minnesota, 55414
About this study
Official title: Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design to Make HIV Clinics More Friendly, Private, and Patient-Centric
The purpose of this study is to test the feasibility and acceptability of implementing clinic system changes and physical structures in Uganda to improve aesthetics, welcome, and privacy to reduce HIV stigma, improve retention-in-care, and improve the patient experience.
To evaluate pilot/implementation outcomes, the outcomes of fidelity, feasibility, and acceptability will be assessed prior to intervention. After the changes are done to two HIV interventions clinics, the outcome surveys will assess if the changes were disruptive or impeded the workings of the clinics.
- Conditions
- Hiv
- Being tested
- Clinics remodeling
- Medical subject headings
- Acquired Immunodeficiency Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Clinics remodelingOther
changes to the clinics will be planned based on baseline surveys
| Study group | Role | What they receive |
|---|---|---|
| Interventions clinics to be remodeled | Experimental | Not described Receives: Other: Clinics remodeling |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability survey
How well an intervention will be received by the target population and the extent to which the intervention meets the needs of the target population and organizational setting. This will be assessed through qualitative evaluation and a quantitative survey from patients and staff.
Measured: Baseline
Feasibility
An assessment of the practicality of a proposed idea or project, by assessing recruitment capacity, and ability to complete proposed modifications in clinics. The intervention will be judged feasible if enrollment and metrics can be completed.
Measured: baseline
Fidelity to the Intervention
Assesses whether the intervention was delivered as intended, using the intervention plan/checklist
Measured: 6-months post intervention
Outcomes survey
assesses if the changes were disruptive or impeded the workings of the clinics.
Measured: 6-months post intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Dec 2022
- Study start30 Jul 2024
- Primary completion30 Jul 2027 (estimated)
- Study completion30 Jul 2027 (estimated)
Why it stopped: Unable to obtain funding
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HivStudies of the same condition, open and under way.
- More trials run by University of MinnesotaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Minnesota
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05642676
- Sponsor's protocol ID
- MED-2023-32453'
- Status last verified
- Sep 2025
- First submitted
- 8 Nov 2022
- Last updated
- 11 Sep 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design to Make HIV Clinics More Friendly, Private, and Patient-Centric
- ClinicalTrials.gov ID
- NCT05642676
- Acronym / sponsor ID
- MED-2023-32453'
- Conditions
- Hiv
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Unable to obtain funding
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of MinnesotaUniversity, hospital or other
- Study start
- 30 Jul 2024 (actual)
- Primary completion
- 30 Jul 2027 (estimated)
- Study completion
- 30 Jul 2027 (estimated)
- First posted
- 8 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to test the feasibility and acceptability of implementing clinic system changes and physical structures in Uganda to improve aesthetics, welcome, and privacy to reduce HIV stigma, improve retention-in-care, and improve the patient experience.
To evaluate pilot/implementation outcomes, the outcomes of fidelity, feasibility, and acceptability will be assessed prior to intervention. After the changes are done to two HIV interventions clinics, the outcome surveys will assess if the changes were disruptive or impeded the workings of the clinics.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Interventions clinics to be remodeled | Experimental | Other: Clinics remodeling |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Adults 18 and older
- Enrolled in the HIV clinics where we are working
- Able to independently consent for interview, survey, or focus group.
Key exclusion criteria (2 listed)
- Unable to provide consent
- Does not speak English or Luganda (local language around Kampala and Entebbe)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Clinics remodelingchanges to the clinics will be planned based on baseline surveys | Other | Interventions clinics to be remodeled |
Primary outcome
Acceptability survey
Time frame: Baseline
How well an intervention will be received by the target population and the extent to which the intervention meets the needs of the target population and organizational setting. This will be assessed through qualitative evaluation and a quantitative survey from patients and staff.
Feasibility
Time frame: baseline
An assessment of the practicality of a proposed idea or project, by assessing recruitment capacity, and ability to complete proposed modifications in clinics. The intervention will be judged feasible if enrollment and metrics can be completed.
Fidelity to the Intervention
Time frame: 6-months post intervention
Assesses whether the intervention was delivered as intended, using the intervention plan/checklist
Outcomes survey
Time frame: 6-months post intervention
assesses if the changes were disruptive or impeded the workings of the clinics.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Hiv
Not yet recruitingPhase 1
huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
Enrolling by invitation
Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection
HIV Infections
RecruitingPhase 1/2
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Tuberculosis
Enrolling by invitation
Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women
HIV, HIV - Human Immunodeficiency Virus
Not yet recruitingPhase 4
Study of BIC/LEN FDC Versus Stable Baseline Regimens in Virologically Suppressed People With HIV
HIV-1 Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Clinics remodeling in people with Hiv, run by University of Minnesota at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 11 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability survey (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2025.